79130027 - ACTAVIS LABORATORIES

Information

  • Trademark
  • 79130027
  • Serial Number
    79130027
  • Registration Number
    4686257
  • Filing Date
    November 21, 2012
    11 years ago
  • Registration Date
    February 17, 2015
    9 years ago
  • Transaction Date
    June 18, 2023
    a year ago
  • Status Date
    November 21, 2022
    a year ago
  • Published for Opposition Date
    March 11, 2014
    10 years ago
  • Location Date
    February 17, 2015
    9 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    YARD, JOHN S
  • Attorney Docket Number
    S7150961
    Attorney Name
    Gabrielle S. Roth
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
4000
Mark Identification
ACTAVIS LABORATORIES
Case File Statements
  • GS0051: Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; oral contraceptives; contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels; pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum for the treatment or prevention of halitosis, cavities, gingivitis, plaque, and dry mouth; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases, all primarily composed of test strips, collection containers, medical diagnostic reagents and assays; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
  • GS0031: Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care; cosmetic skin fresheners and toners; cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, non-medicated mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention and treatment of illnesses, diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the sensory system, and the genitourinary system, in the treatment of inflammatory disorders and diseases, and for treatment in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastroenterology; and chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
  • D10000: "LABORATORIES"
  • GS0421: Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
Case File Event Statements
  • 6/17/2023 - a year ago
    55 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 6/17/2023 - a year ago
    54 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 10/22/2022 - a year ago
    53 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/22/2022 - a year ago
    52 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 8/2/2022 - a year ago
    51 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 8/2/2022 - a year ago
    50 - INVALIDATION PROCESSED Type: INPC
  • 5/3/2022 - 2 years ago
    49 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 9/3/2021 - 2 years ago
    48 - CANCELLED SECTION 71 Type: C71T
  • 2/17/2020 - 4 years ago
    47 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 7/17/2015 - 8 years ago
    46 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/1/2015 - 9 years ago
    45 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/1/2015 - 9 years ago
    44 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/17/2015 - 9 years ago
    43 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/17/2015 - 9 years ago
    42 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/14/2015 - 9 years ago
    41 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 1/14/2015 - 9 years ago
    40 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 1/14/2015 - 9 years ago
    39 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 10/3/2014 - 9 years ago
    38 - REFUSAL PROCESSED BY IB Type: RFNP
  • 9/4/2014 - 9 years ago
    37 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 9/3/2014 - 9 years ago
    36 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 9/3/2014 - 9 years ago
    35 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 3/24/2014 - 10 years ago
    34 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 3/11/2014 - 10 years ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/11/2014 - 10 years ago
    32 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/7/2014 - 10 years ago
    31 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/19/2014 - 10 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/19/2014 - 10 years ago
    29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/19/2014 - 10 years ago
    28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/4/2014 - 10 years ago
    27 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/4/2014 - 10 years ago
    26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/4/2014 - 10 years ago
    25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/4/2014 - 10 years ago
    24 - ASSIGNED TO LIE Type: ALIE
  • 2/4/2014 - 10 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/3/2014 - 10 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/3/2014 - 10 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/3/2014 - 10 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/28/2013 - 10 years ago
    19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/28/2013 - 10 years ago
    18 - FINAL REFUSAL E-MAILED Type: GNFR
  • 8/28/2013 - 10 years ago
    17 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/25/2013 - 10 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/24/2013 - 10 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/24/2013 - 10 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/16/2013 - 10 years ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/16/2013 - 10 years ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/9/2013 - 10 years ago
    11 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV
  • 7/6/2013 - 10 years ago
    10 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 7/1/2013 - 11 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/7/2013 - 11 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/7/2013 - 11 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/7/2013 - 11 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/6/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/4/2013 - 11 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/31/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/31/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/30/2013 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR